fondaparinux(Arixtra):急性冠症候群:OASIS 5 ・ 6 トライアル



Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes. An Individual Patient–Level Combined Analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) Randomized Trial
Circulation Published Online on October 27, 2008

by internalmedicine | 2008-10-29 08:32 | 動脈硬化/循環器  

<< 生物学的製剤の安全性規制アクシ... 固形癌入院患者へのスタチン投与... >>